| 子宫颈癌预防用人乳头瘤病毒疫苗及其展拓 |
| |
| 引用本文： | 于永利. 子宫颈癌预防用人乳头瘤病毒疫苗及其展拓[J]. 微生物学免疫学进展, 2013, 0(1): 1-6 |
| |
| 作者姓名： | 于永利 |
| |
| 作者单位： | 吉林大学白求恩医学院免疫学系 |
| |
| 摘 要： | 人乳头瘤病毒(HPV)是人子宫颈癌病原体,这一发现奠定了子宫颈癌预防用人乳头瘤病毒疫苗得以问世的科学基础。临床实践证明,默克(Merck)公司的Gardasil和葛兰素史克(GSK)公司的Cervarix这两种疫苗可预防由HPV16和HPV18引起的子宫颈癌,有效率几乎达100%。Gardasil和Cervarix的成功激动了围绕Gardasil和Cervar-ix的展拓研究。
|
| 关 键 词： | 人乳头瘤病毒 子宫颈癌 疫苗 |
The discovery that human papilloma virus(HPV) caused human cervical cancer |
| |
| YU Yong-li. The discovery that human papilloma virus(HPV) caused human cervical cancer[J]. Progress In Microbiology and Immunology, 2013, 0(1): 1-6 |
| |
| Authors: | YU Yong-li |
| |
| Affiliation: | YU Yong-li(Department of Immunology,Norman Bethune College of Medicine Jilin University,Changchun 130021,China) |
| |
| Abstract: | The discovery that human papilloma virus(HPV) caused human cervical cancer provided scientific basis for the commercialization of therapeutic vaccines against cervical cancers.Accumulating data showed that both Gardasil,a vaccine from Merck,and Cervarix,a vaccine from GSK,protected almost 100% vaccinated women from developing cervical cancers caused by HPV16 and HPV18. |
| |
| Keywords: | Human papilloma virus Cervical cancer Vaccine |
| 本文献已被 CNKI 等数据库收录！ |
|
